Catalyst Wire Dossier Catalyst Wire Dossier

Synflorix (PHiD-CV)

pneumococcal 10-valent conjugate vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Synflorix (PHiD-CV), covering 2017-03-03 to 2017-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada

See pricing